Key Events This Week
2 Mar: Stock hits 52-week low of Rs.324.6 amid gap down opening
4 Mar: Further decline to new 52-week low of Rs.315.6
5 Mar: Minor recovery with a 0.61% gain
6 Mar: Week closes at Rs.324.05, down 0.31% on the day
2 March: Sharp Gap Down and New 52-Week Low
Unichem Laboratories opened the week with a significant gap down of 6.51%, settling at Rs.330.50 on 2 March 2026. The stock hit an intraday low of Rs.324.6, marking a fresh 52-week low. This decline was sharper than the Sensex’s 1.41% fall, with the stock losing 4.81% on the day. The gap down reflected mounting market concerns over the company’s financial health, including a high Debt to EBITDA ratio of 4.87 times and a recent sharp drop in quarterly profit before tax excluding other income (PBT LESS OI) by 77.2%.
Technical indicators remained bearish, with the stock trading below all key moving averages and showing high intraday volatility of 466.82%. Despite the broader market’s partial recovery from steep losses, Unichem’s shares continued to face selling pressure, underscoring investor caution.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
4 March: Continued Downtrend to Rs.315.6
The downward momentum persisted on 4 March, with Unichem Laboratories’ stock falling 2.72% to Rs.321.50, hitting a new 52-week low of Rs.315.6 during the session. This extended the losing streak to four consecutive trading days, accumulating a 9.27% decline. The stock underperformed its Pharmaceuticals & Biotechnology sector by 0.52% and the Sensex by 1.92% on the day.
Financial pressures remained evident, with the company’s Profit After Tax (PAT) for the December 2025 quarter down 56.0% to Rs.16.13 crore and interest expenses rising 30.50% to Rs.15.66 crore over the latest six months. Despite these challenges, operating profit growth was robust at an annualised 148.09%, and valuation metrics such as the Price/Earnings to Growth (PEG) ratio of 0.7 suggested the stock was trading at a discount relative to earnings growth.
5 March: Minor Recovery Amid Volatile Trading
On 5 March, Unichem Laboratories saw a modest rebound, gaining 0.61% to close at Rs.323.45. This slight recovery came alongside a 1.29% rise in the Sensex, indicating some short-term stabilisation after the prior days’ declines. Trading volume remained steady at 4,711 shares, reflecting cautious investor interest. However, the stock remained below all key moving averages, signalling that the broader downtrend was intact.
Unichem Laboratories Ltd or something better? Our SwitchER feature analyzes this small-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
6 March: Week Ends with Slight Loss
The week concluded on 6 March with Unichem Laboratories’ stock inching up 0.19% to Rs.324.05, marginally recovering from the prior day’s close. The Sensex, however, declined 0.98%, closing at 35,232.05. The stock’s volume dropped sharply to 905 shares, indicating reduced trading activity. Despite the slight gain, the stock’s weekly performance remained negative at -6.67%, reflecting sustained investor caution amid ongoing financial and operational challenges.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-03-02 | Rs.330.50 | -4.81% | 35,812.02 | -1.41% |
| 2026-03-04 | Rs.321.50 | -2.72% | 35,125.64 | -1.92% |
| 2026-03-05 | Rs.323.45 | +0.61% | 35,579.03 | +1.29% |
| 2026-03-06 | Rs.324.05 | +0.19% | 35,232.05 | -0.98% |
Key Takeaways
Persistent Downtrend: Unichem Laboratories experienced a sustained decline over the week, hitting new 52-week lows on two occasions. The stock’s 6.67% weekly loss notably exceeded the Sensex’s 3.00% fall, highlighting company-specific pressures.
Financial and Operational Challenges: Elevated debt levels with a Debt to EBITDA ratio of 4.87 times, declining profitability with a 77.2% drop in quarterly PBT excluding other income, and rising interest expenses have weighed heavily on investor sentiment.
Valuation and Efficiency Signals: Despite the negative price action, operating profit growth at 148.09% annually and an attractive enterprise value to capital employed ratio of 1 suggest some operational improvements and valuation appeal relative to peers.
Technical Weakness: The stock remained below all key moving averages throughout the week, with bearish technical indicators signalling continued downward momentum.
Conclusion
Unichem Laboratories Ltd’s share price performance during the week ending 6 March 2026 reflects a challenging environment marked by fresh 52-week lows, weak quarterly earnings, and elevated leverage concerns. While some operational metrics indicate improving efficiency, these have yet to translate into positive price momentum. The stock’s underperformance relative to the Sensex and sector peers underscores ongoing investor caution. Market participants will likely continue to monitor financial results and technical signals closely as the company navigates these headwinds.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
